Cargando…

Hypermethylation of SCAND3 and Myo1g Gene Are Potential Diagnostic Biomarkers for Hepatocellular Carcinoma

Presently, there is a lack of effective blood-based biomarkers facilitating the diagnosis of hepatocellular carcinoma (HCC). Thus, we aimed to investigate novel methylation markers for HCC diagnosis, and explore relationships between biomarker methylation and clinicopathology of HCC. The methylation...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Fei, Zhang, Lulu, Xu, Yuxia, Song, Di, He, Wenting, Ji, Xiaomeng, Shao, Jianyong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7465898/ https://www.ncbi.nlm.nih.gov/pubmed/32824823 http://dx.doi.org/10.3390/cancers12082332

Ejemplares similares

The Diagnostic Value of Serum PIVKA-II Alone or in Combination with AFP in Chinese Hepatocellular Carcinoma Patients
por: Xu, Fei, et al.
Publicado: (2021)

Stress-Inducible SCAND Factors Suppress the Stress Response and Are Biomarkers for Enhanced Prognosis in Cancers
por: Sheta, Mona, et al.
Publicado: (2023)

Complex effects of mammalian grazing on extramatrical mycelial biomass in the Scandes forest‐tundra ecotone
por: Vowles, Tage, et al.
Publicado: (2017)

Identification of RASSF1A promoter hypermethylation as a biomarker for hepatocellular carcinoma
por: Xu, Gang, et al.
Publicado: (2020)

Expansion of deciduous tall shrubs but not evergreen dwarf shrubs inhibited by reindeer in Scandes mountain range
por: Vowles, Tage, et al.
Publicado: (2017)

MZF1 and SCAND1 Reciprocally Regulate CDC37 Gene Expression in Prostate Cancer
por: Eguchi, Takanori, et al.
Publicado: (2019)

SCAND1 Reverses Epithelial-to-Mesenchymal Transition (EMT) and Suppresses Prostate Cancer Growth and Migration
por: Eguchi, Takanori, et al.
Publicado: (2022)

ESRRG promoter hypermethylation as a diagnostic and prognostic biomarker in laryngeal squamous cell carcinoma
por: Shen, Zhisen, et al.
Publicado: (2019)

The lipid peroxidation-derived DNA adduct γ-OHPdG as a diagnostic and prognostic biomarker in hepatocellular carcinoma
por: Cao, Qiwei, et al.
Publicado: (2023)

Genome-scale detection of hypermethylated CpG islands in circulating cell-free DNA of hepatocellular carcinoma patients
por: Wen, Lu, et al.
Publicado: (2015)

SCTR hypermethylation is a diagnostic biomarker in colorectal cancer
por: Li, DaPeng, et al.
Publicado: (2020)

On the transposon origins of mammalian SCAND3 and KRBA2, two zinc-finger genes carrying an integrase/transposase domain
por: Llorens, Carlos, et al.
Publicado: (2012)

Circulating Hypermethylated RASSF1A as a Molecular Biomarker for Diagnosis of Hepatocellular Carcinoma
por: Mansour, Lamiaa A, et al.
Publicado: (2017)

Hypermethylation Leads to Bone Morphogenetic Protein 6 Downregulation in Hepatocellular Carcinoma
por: He, Yinghua, et al.
Publicado: (2014)

SIP1 is downregulated in hepatocellular carcinoma by promoter hypermethylation
por: Acun, Tolga, et al.
Publicado: (2011)

The Silencing of RECK Gene is Associated with Promoter Hypermethylation and Poor Survival in Hepatocellular Carcinoma
por: Zhang, Changsong, et al.
Publicado: (2012)

Is APC hypermethylation a diagnostic biomarker for bladder cancer? A meta-analysis
por: Han, Wei, et al.
Publicado: (2018)

Hypermethylation of multiple genes as clonal markers in multicentric hepatocellular carcinoma
por: Nomoto, S, et al.
Publicado: (2007)

Hypermethylation of DNA Methylation Markers in Non-Cirrhotic Hepatocellular Carcinoma
por: Fu, Siyu, et al.
Publicado: (2023)

Alu hypomethylation and MGMT hypermethylation in serum as biomarkers of glioma
por: Gong, Mingjie, et al.
Publicado: (2017)

Hypermethylation of APC2 Is a Predictive Epigenetic Biomarker for Chinese Colorectal Cancer
por: He, Yuan, et al.
Publicado: (2018)

Hypermethylated genes as biomarkers of breast cancer
por: Fackler, MJ, et al.
Publicado: (2009)

Promoter DNA methylation analysis reveals a novel diagnostic CpG-based biomarker and RAB25 hypermethylation in clear cell renel cell carcinoma
por: Gu, Yinmin, et al.
Publicado: (2017)

Characterization of the promoter region of the bovine SIX1 gene: Roles of MyoD, PAX7, CREB and MyoG
por: Wei, Da-wei, et al.
Publicado: (2017)

Actin-related protein 5 functions as a novel modulator of MyoD and MyoG in skeletal muscle and in rhabdomyosarcoma
por: Morita, Tsuyoshi, et al.
Publicado: (2022)

CpG Island Hypermethylation in Gastric Carcinoma and Its Premalignant Lesions
por: Kang, Gyeong Hoon
Publicado: (2012)

Value of KPNA4 as a diagnostic and prognostic biomarker for hepatocellular carcinoma
por: Xu, Mingxing, et al.
Publicado: (2021)

Hypermethylation of the PZP gene is associated with hepatocellular carcinoma cell proliferation, invasion and migration
por: Wu, Minhua, et al.
Publicado: (2021)

DNA hypermethylation of the promoter attenuates forkhead box protein 3 (FOXP3) expression in hepatocellular carcinoma cells
por: Lin, Zewei, et al.
Publicado: (2019)

CpG island hypermethylation go circular (RNA)
por: Dragomir, Mihnea P., et al.
Publicado: (2018)

Role of hypermethylated SLC5A8 in follicular thyroid cancer diagnosis and prognosis prediction
por: Yang, Yan, et al.
Publicado: (2023)

Identification of the Diagnostic Biomarker VIPR1 in Hepatocellular Carcinoma Based on Machine Learning Algorithm
por: Ge, Song, et al.
Publicado: (2022)

Early diagnostic potential of APC hypermethylation in esophageal cancer
por: Wang, Bujiang, et al.
Publicado: (2018)

Biomarkers for hepatocellular carcinoma: diagnostic and therapeutic utility
por: Ferrín, Gustavo, et al.
Publicado: (2015)

Cell Cycle Genes Are Potential Diagnostic and Prognostic Biomarkers in Hepatocellular Carcinoma
por: Liping, Xu, et al.
Publicado: (2020)

Promoter Hypermethylation Mediated Downregulation of FBP1 in Human Hepatocellular Carcinoma and Colon Cancer
por: Chen, Mingquan, et al.
Publicado: (2011)

Hypermethylation and Expression Silencing of PDCD4 Gene in Hepatocellular Carcinoma: A Consort Study
por: Ding, Xianglian, et al.
Publicado: (2016)

Silencing HOXD10 by promoter region hypermethylation activates ERK signaling in hepatocellular carcinoma
por: Guo, Yulin, et al.
Publicado: (2017)

DNA hypermethylation of aurora kinase A in hepatitis C virus-positive hepatocellular carcinoma
por: Ma, Zuohong, et al.
Publicado: (2019)

Clinicopathological and prognostic significance of CDH1 hypermethylation in hepatocellular carcinoma: a meta-analysis
por: Wu, Xiaoyu, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_pv0fmg1rolj88r6fo147s0bstc